Our 2021 Open Call was very competitive, and we received a number of high-quality applications. Each application was assessed by our awards panel and underwent a rigorous external peer review in line with Association of Medical Research Charities (AMRC) guidelines.
The four successful projects will begin in early 2022 and aim to hugely impact the lives of people with Crohn’s and Colitis.
Impact of Biologic Therapy on SARS-COV-2 Infection and Immunity (CLARITY IBD)
Dr Tariq Ahmad – Royal Devon and Exeter NHS Foundation Trust
Award: £43,427.42
Duration: 10 months
Molecular classification of patients with Ulcerative Colitis to enable personalised medicine – a feasibility cohort study
Dr Matthias Friedrich – University of Oxford
Award: £76,988.28
Duration: 24 months
Using machine-learning to predict intestinal inflammation in asymptomatic relatives of patients with Crohn’s Disease
Dr Natalie Prescott – King’s College London
Award: £99,754
Duration: 24 months
Feasibility study to assess the implementation of routine mental health screening and guided web-based Cognitive Behavioural Therapy (CBT) tailored for treating anxiety and depression in IBD in a large NHS gastroenterology service
Dr Federica Picariello and Prof Rona Moss-Morris
Award: £98,571.18
Duration: 18 months
We’re looking forward to sharing updates with you on the progress of these projects and the impact they could have for people living with Crohn’s and Colitis. If you would like to get involved in research, please visit our research involvement page and sign up to our community to be the first to hear about new ways you can take part.